FDA seeks more studies on female sex pill

FDA seeks more studies on female sex pill

But in a news release, Sprout Pharmaceuticals President Cindy Whitehead described the development as a "significant step toward the approval of flibanserin." The three studies requested by the FDA are relatively small, involving 25 to 50 patients each.

6
Like
Save

Comments

Write a comment

*